Initial Statement of Beneficial Ownership (3)
February 11 2019 - 6:42PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
NOLAN KERMIT
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
2/7/2019
|
3. Issuer Name
and
Ticker or Trading Symbol
SYNAPTICS Inc [SYNA]
|
(Last)
(First)
(Middle)
1251 MCKAY DRIVE
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
See Remarks /
|
(Street)
SAN JOSE, CA 95131
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
56111
(1)
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Stock Option (Right to Buy)
|
(2)
|
8/3/2019
|
Common Stock
|
5109
(3)
|
$25.50
|
D
|
|
Employee Stock Option (Right to Buy)
|
(4)
|
8/2/2020
|
Common Stock
|
13000
|
$31.73
|
D
|
|
Employee Stock Option (Right to Buy)
|
(5)
|
10/31/2019
|
Common Stock
|
1000
|
$23.16
|
D
|
|
Employee Stock Option (Right to Buy)
|
(6)
|
1/28/2020
|
Common Stock
|
1000
|
$35.76
|
D
|
|
Employee Stock Option (Right to Buy)
|
(7)
|
4/29/2020
|
Common Stock
|
1000
|
$42.57
|
D
|
|
Employee Stock Option (Right to Buy)
|
(8)
|
8/5/2020
|
Common Stock
|
1000
|
$39.80
|
D
|
|
Employee Stock Option (Right to Buy)
|
(9)
|
10/28/2020
|
Common Stock
|
744
|
$46.50
|
D
|
|
Employee Stock Option (Right to Buy)
|
(10)
|
1/27/2021
|
Common Stock
|
744
|
$60.22
|
D
|
|
Employee Stock Option (Right to Buy)
|
(11)
|
4/28/2021
|
Common Stock
|
744
|
$61.40
|
D
|
|
Employee Stock Option (Right to Buy)
|
(12)
|
8/1/2021
|
Common Stock
|
745
|
$78.11
|
D
|
|
Employee Stock Option (Right to Buy)
|
(13)
|
10/24/2021
|
Common Stock
|
408
|
$62.105
|
D
|
|
Employee Stock Option (Right to Buy)
|
(14)
|
1/30/2022
|
Common Stock
|
408
|
$76.81
|
D
|
|
Employee Stock Option (Right to Buy)
|
(15)
|
4/24/2022
|
Common Stock
|
408
|
$85.69
|
D
|
|
Employee Stock Option (Right to Buy)
|
(16)
|
7/31/2022
|
Common Stock
|
408
|
$79.38
|
D
|
|
Employee Stock Option (Right to Buy)
|
(17)
|
10/23/2022
|
Common Stock
|
1049
|
$89.29
|
D
|
|
Employee Stock Option (Right to Buy)
|
(18)
|
1/23/2023
|
Common Stock
|
1050
|
$73.31
|
D
|
|
Employee Stock Option (Right to Buy)
|
(19)
|
4/29/2023
|
Common Stock
|
1049
|
$71.55
|
D
|
|
Employee Stock Option (Right to Buy)
|
(20)
|
7/23/2023
|
Common Stock
|
1050
|
$51.95
|
D
|
|
Explanation of Responses:
|
(1)
|
Includes (i) 7,648 shares that were acquired upon delivery of vested deferred stock units, (ii) 17,531 shares underlying deferred stock units that are not yet vested and deliverable, and (iii) 1,354 shares released in connection with the vesting of performance-based market stock units granted on 12/13/17.
|
(2)
|
25% of the 18,000 shares subject to the option vested and became exercisable on the 12 month anniversary of the 7/27/09 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 27th day of each month thereafter until fully vested on 7/27/13.
|
(3)
|
Does not include 12,891 shares underlying the option that were previously exercised.
|
(4)
|
1/48th of the total number of shares subject to the option vested and became exercisable on the 2nd day of each month following the 8/02/10 date of grant until fully vested on 8/02/14.
|
(5)
|
1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the 10/31/12 date of grant until fully vested on 10/29/15.
|
(6)
|
1/36th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the 1/28/13 date of grant until fully vested on 1/28/16.
|
(7)
|
1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the 4/29/13 date of grant until fully vested on 4/29/16.
|
(8)
|
1/36th of the total number of shares subject to the option vested and became exercisable on the 5th day of each month following the 8/05/13 date of grant until fully vested on 8/05/16.
|
(9)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/28/13 date of grant until fully vested on 10/28/16.
|
(10)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/27/14 date of grant until fully vested on 1/27/17.
|
(11)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 4/28/14 date of grant until fully vested on 4/28/17.
|
(12)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 8/01/14 date of grant until fully vested on 8/01/17.
|
(13)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/24/14 date of grant until fully vested on 10/24/17.
|
(14)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/30/15 date of grant until fully vested on 1/30/18.
|
(15)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 4/24/15 date of grant until fully vested on 4/24/18.
|
(16)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 7/31/15 date of grant until fully vested on 7/31/18.
|
(17)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/23/15 date of grant until fully vested on 10/23/18.
|
(18)
|
1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/29/16 date of grant until fully vested on 1/29/19.
|
(19)
|
1/12th of the total number of shares subject to the option vested or shall vest and became exercisable or shall become exercisable each quarter following the 4/29/16 date of grant until fully vested on 4/29/19.
|
(20)
|
1/12th of the total number of shares subject to the option vested or shall vest and became exercisable or shall become exercisable each quarter following the 7/29/16 date of grant until fully vested on 7/29/19.
|
Remarks:
The reporting person is the Corporate Vice President, Chief Accounting Officer, and Interim Chief Financial Officer.
Exhibit List
Exhibit 24 - Limited Power of Attorney
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
NOLAN KERMIT
1251 MCKAY DRIVE
SAN JOSE, CA 95131
|
|
|
See Remarks
|
|
Signatures
|
Kermit Nolan
|
|
2/11/2019
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Synaptics (NASDAQ:SYNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Synaptics (NASDAQ:SYNA)
Historical Stock Chart
From Apr 2023 to Apr 2024